VITRO DIAGNOSTICS INC
10QSB, EX-27, 2000-06-29
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: VITRO DIAGNOSTICS INC, 10QSB, EX-99, 2000-06-29
Next: GLOBAL/INTERNATIONAL FUND INC, NT-NSAR, 2000-06-29



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

This  schedule  contains  summary  financial   information  extracted  from  the
Statement of Financial Condition at April 30, 2000 (Unaudited) and the Statement
of Income for the Quarter Ended April 30, 2000  (Unaudited).  It is qualified in
its entirety by reference to such financial statements.

</LEGEND>


<S>                                       <C>
<PERIOD-TYPE>                           6-MOS
<FISCAL-YEAR-END>                       Oct-31-2000
<PERIOD-END>                            Apr-30-2000
<CASH>                                            0
<SECURITIES>                                      0
<RECEIVABLES>                               293,506
<ALLOWANCES>                                      0
<INVENTORY>                                 218,960
<CURRENT-ASSETS>                            568,841
<PP&E>                                      208,249
<DEPRECIATION>                              151,699
<TOTAL-ASSETS>                              802,222
<CURRENT-LIABILITIES>                       260,198
<BONDS>                                           0
<COMMON>                                    283,036
                             0
                                       0
<OTHER-SE>                                  153,556
<TOTAL-LIABILITY-AND-EQUITY>                802,222
<SALES>                                     570,155
<TOTAL-REVENUES>                            570,155
<CGS>                                       188,333
<TOTAL-COSTS>                               188,333
<OTHER-EXPENSES>                            399,587
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                            9,815
<INCOME-PRETAX>                            (333,871)
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                               0
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                               (333,871)
<EPS-BASIC>                                 (0.04)
<EPS-DILUTED>                                 (0.04)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission